2. Duration of Therapy
Nitazoxanide is FDA-approved for three days of therapy to manage cryptosporidiosis and giardiasis in immunocompetent adult and pediatric patients, as documented in clinical trials. Treatment durations exceeding these recommendations will be reviewed.